X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: influence on their redox properties

The Gly‐His‐Lys (GHK) peptide and the Asp‐Ala‐His‐Lys (DAHK) sequences are naturally occurring high‐affinity copper(II) chelators found in the blood plasma and are hence of biological interest. A structural study of the copper complexes of these peptides was conducted in the solid state and in solution by determining their X‐ray structures, and by using a large range of spectroscopies, including EPR and HYSCORE (hyperfine sub‐level correlation), X‐ray absorption and ¹H and ¹³C NMR spectroscopy. The results indicate that the structures of Cu^II(DAHK)] in the solid state and in solution are similar and confirm the equatorial coordination sphere of NH₂, two amidyl N and one imidazole N. Additionally, a water molecule is bound apically to Cu^II as revealed by the X‐ray structure. As reported previously in the literature, Cu^II(GHK)], which exhibits a dimeric structure in the solid state, forms a monomeric complex in solution with three nitrogen ligands: NH₂, amidyl and imidazole. The fourth equatorial site is occupied by a labile oxygen atom from a carboxylate ligand in the solid state. We probe that fourth position and study ternary complexes of Cu^II(GHK)] with glycine or histidine. The Cu^II exchange reaction between different DAHK peptides is very slow, in contrast to Cu^II(GHK)], in which the fast exchange was attributed to the presence of a Cu^II(GHK)₂] complex. The redox properties of Cu^II(GHK)] and Cu^II(DAHK)] were investigated by cyclic voltammetry and by measuring the ascorbate oxidation in the presence of molecular oxygen. The measurements indicate that both Cu^II complexes are inert under moderate redox potentials. In contrast to Cu^II(DAHK)], Cu^II(GHK)] could be reduced to Cu^I around ?0.62 V (versus AgCl/Ag) with subsequent release of the Cu ion. These complete analyses of structure and redox activity of those complexes gave new insights with biological impact and can serve as models for other more complicated Cu^II–peptide interactions.